These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34990622)

  • 21. Correlation of FISH and PRAME Immunohistochemistry in Ambiguous Superficial Cutaneous Melanocytic Proliferations.
    Harvey NT; Peverall J; Acott N; Mesbah Ardakani N; Leecy TN; Iacobelli J; McCallum D; Van Vliet C; Wood BA
    Am J Dermatopathol; 2021 Dec; 43(12):913-920. PubMed ID: 33899766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Analysis of PRAME Expression in 127 Acral and Nail Melanocytic Lesions.
    Santandrea G; Valli R; Zanetti E; Ragazzi M; Pampena R; Longo C; Lai M; Piana S; Cesinaro AM
    Am J Surg Pathol; 2022 May; 46(5):579-590. PubMed ID: 35275883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemistry for PRAME in Dermatopathology.
    Lezcano C; Jungbluth AA; Busam KJ
    Am J Dermatopathol; 2023 Nov; 45(11):733-747. PubMed ID: 37856737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Application of immunohistochemical staining of PRAME in differential diagnosis between melanoma and melanocytic nevus].
    Du J; Yu WJ; Guo RP; Su J
    Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):621-626. PubMed ID: 35785832
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunohistochemistry for Preferentially Expressed Antigen in Melanoma in the Differential Diagnosis of Melanocytic Lesions of the Nail Apparatus.
    Krajisnik A; Gharavi NM; Faries MB; Balzer BL; Frishberg DP; Martelli M; Shon W
    Am J Dermatopathol; 2022 Jul; 44(7):488-492. PubMed ID: 35120028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin D1 and PRAME expression in distinguishing melanoma in situ from benign melanocytic proliferation of the nail unit.
    Kim YJ; Jung CJ; Na H; Lee WJ; Chang SE; Lee MW; Park CS; Lim Y; Won CH
    Diagn Pathol; 2022 Apr; 17(1):41. PubMed ID: 35484605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PRAME Immunohistochemistry for Distinguishing Vulvar and Vaginal Melanoma From Benign Melanocytic Nevi.
    Martin SD; Martin KC; Gilks CB; Crawford RI; Hoang LN
    Int J Gynecol Pathol; 2024 Jul; 43(4):389-396. PubMed ID: 38085951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refining the application of PRAME-a useful marker in high CSD and acral melanoma subtypes.
    Wakefield C; O'Keefe L; Heffron CCBB
    Virchows Arch; 2023 Dec; 483(6):847-854. PubMed ID: 37723345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRAME Immunohistochemical Expression and TERT Promoter Mutational Analysis as Ancillary Diagnostic Tools for Differentiating Proliferative Nodules From Melanoma Arising in Congenital Nevi.
    Boutko A; Hagstrom M; Lampley N; Roth A; Olivares S; Dhillon S; Fumero-Velázquez M; Benton S; Zhao J; Zhang B; Dittmann D; Asadbeigi S; Busam KJ; Gerami P
    Am J Dermatopathol; 2023 Jul; 45(7):437-447. PubMed ID: 37338065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of PRAME immunostaining to distinguish early melanoma in situ from benign pigmented conditions.
    Olds H; Utz S; Abrams J; Terrano D; Mehregan D
    J Cutan Pathol; 2022 Jun; 49(6):510-514. PubMed ID: 35146798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PRAME Expression in Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Nehal KS; Hollmann TJ; Busam KJ
    Am J Surg Pathol; 2018 Nov; 42(11):1456-1465. PubMed ID: 30045064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferentially expressed antigen in melanoma immunohistochemistry as an adjunct for differential diagnosis in acral lentiginous melanoma and acral nevi.
    Hu J; Cai X; Lv JJ; Wan XC; Zeng XY; Feng ML; Dai B; Kong YY
    Hum Pathol; 2022 Feb; 120():9-17. PubMed ID: 34800527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.
    Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R
    Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferentially expressed antigen in melanoma and p16 expression in acral melanocytic neoplasms.
    McBride JD; McAfee JL; Piliang M; Bergfeld WF; Fernandez AP; Ronen S; Billings SD; Ko JS
    J Cutan Pathol; 2022 Mar; 49(3):220-230. PubMed ID: 34476825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME).
    Grillini M; Ricci C; Pino V; Pedrini S; Fiorentino M; Corti B
    Appl Immunohistochem Mol Morphol; 2022 Jan; 30(1):14-18. PubMed ID: 34508017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PRAME Expression in Mucosal Melanoma of the Head and Neck Region.
    Ricci C; Altavilla MV; Corti B; Pasquini E; Presutti L; Baietti AM; Amorosa L; Balbi T; Baldovini C; Ambrosi F; Grillini M; D'Errico A; Fiorentino M; Foschini MP
    Am J Surg Pathol; 2023 May; 47(5):599-610. PubMed ID: 36912431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemistry for PRAME in the Distinction of Nodal Nevi From Metastatic Melanoma.
    Lezcano C; Pulitzer M; Moy AP; Hollmann TJ; Jungbluth AA; Busam KJ
    Am J Surg Pathol; 2020 Apr; 44(4):503-508. PubMed ID: 31633488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic utility of PRAME expression by immunohistochemistry in subungual and non-subungual acral melanocytic lesions.
    Rothrock AT; Torres-Cabala CA; Milton DR; Cho WC; Nagarajan P; Vanderbeck K; Curry JL; Ivan D; Prieto VG; Aung PP
    J Cutan Pathol; 2022 Oct; 49(10):859-867. PubMed ID: 35794643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Digital quantification of PRAME for distinguishing melanoma from nevi compared to manual assessment.
    Enevoldsen J; Brogård MB; Lade-Keller J; Christensen KB; Georgsen JB; Nielsen PS; Steiniche T
    Pathol Res Pract; 2024 Oct; 262():155543. PubMed ID: 39154604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FLI-1/Melan-A dual stain is an alternative to PRAME in differentiating metastatic melanoma from nodal nevus: A monocentric retrospective study.
    Zengin HB; Yildiz B; Pukhalskaya T; Smoller BR
    J Cutan Pathol; 2023 Mar; 50(3):247-258. PubMed ID: 36454046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.